%A LIANG Xue-feng %T Cytokineinduced killer cells in cancer treatment %0 Journal Article %D 2012 %J Journal of International Oncology %R %P 344-347 %V 39 %N 5 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_8781.shtml} %8 2012-05-08 %X Cytokineinduced killer cells (CIK) is the fourth largest cancer treatment after surgery, chemotherapy and radiotherapy, and it is the development direction of cancer treatment. It is a new type of immune cell, and it is named after natural killer cell samples T lymphocytes as it express CD3 and CD56. Currently, CIK treatment has a broader range of clinical applications, and it has achieved the better clinical efficacy in the blood system cancer and solid tumors. The CIK adoptive immunotherapy is considered to be a new hope for the anticancer treatment.